|
SFRS14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.80819999998183E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.73469999999299E-05 |
| Normal-vs-Stage2 |
1.014080E-02 |
| Normal-vs-Stage3 |
2.2017000000929E-07 |
| Normal-vs-Stage4 |
1.623050E-03 |
| Stage1-vs-Stage2 |
5.902400E-01 |
| Stage1-vs-Stage3 |
6.276300E-02 |
| Stage1-vs-Stage4 |
9.336000E-01 |
| Stage2-vs-Stage3 |
7.229700E-02 |
| Stage2-vs-Stage4 |
6.328600E-01 |
| Stage3-vs-Stage4 |
2.111800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.67969999967477E-07 |
| Normal-vs-AfricanAmerican |
2.723600E-01 |
| Normal-vs-Asian |
9.158800E-01 |
| Caucasian-vs-AfricanAmerican |
2.241000E-03 |
| Caucasian-vs-Asian |
8.843500E-02 |
| AfricanAmerican-vs-Asian |
6.845400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.21490000176894E-08 |
| Normal-vs-Female |
1.202390E-02 |
| Male-vs-Female |
1.229030E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.190300E-04 |
| Normal-vs-Age(41-60Yrs) |
2.035700E-04 |
| Normal-vs-Age(61-80Yrs) |
3.56840000004244E-06 |
| Normal-vs-Age(81-100Yrs) |
5.258000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.526000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.185800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.628200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.557200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.732400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.059400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.048000E-01 |
| Normal-vs-Grade 2 |
6.14460000000205E-05 |
| Normal-vs-Grade 3 |
1.2496000000306E-06 |
| Normal-vs-Grade 4 |
2.16749999999433E-05 |
| Grade 1-vs-Grade 2 |
7.743800E-03 |
| Grade 1-vs-Grade 3 |
2.037600E-03 |
| Grade 1-vs-Grade 4 |
3.323800E-03 |
| Grade 2-vs-Grade 3 |
3.856200E-01 |
| Grade 2-vs-Grade 4 |
2.178600E-01 |
| Grade 3-vs-Grade 4 |
5.231200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.36120000000262E-05 |
| Normal-vs-ccB subtype |
9.55710000027921E-07 |
| ccA subtype-vs-ccB subtype |
7.496000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.043890E-04 |
| Normal-vs-N1 |
4.348200E-02 |
| N0-vs-N1 |
9.761200E-01 |
|
|
